Comparison of Two Minimally Invasive Surgical Techniques for Hip Replacement - Full Text View

Sponsored by:	University of British Columbia
Information provided by:	University of British Columbia
ClinicalTrials.gov Identifier:	NCT00175461

Purpose

Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in primary total hip arthroplasty

Condition	Intervention	Phase
Osteoarthritis	Procedure: hip surgery	Phase I

Study Type:	Interventional
Study Design:	Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Official Title:	Comparison of the Clinical Effectiveness and Cost-Effectiveness of the MIS Anterolateral Approach (MIS Watson Jones, G3) Versus Anterolateral Mini or Posterolateral Mini Approaches in Primary Total Hip Arthroplasty

Resource links provided by NLM:

MedlinePlus related topics: Osteoarthritis Surgery

U.S. FDA Resources

Further study details as provided by University of British Columbia:

Primary Outcome Measures:

3-months WOMAC score [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Cost-effectiveness at 2-years [ Time Frame: Two years ] [ Designated as safety issue: No ]

Estimated Enrollment:	156
Study Start Date:	September 2005
Estimated Study Completion Date:	December 2010
Primary Completion Date:	April 2009 (Final data collection date for primary outcome measure)

Intervention Details:

Comparison of the clinical effectiveness and cost-effectiveness of the MIS anterolateral approach (MIS Watson Jones, G3) versus anterolateral mini or posterolateral mini approaches in primary total hip arthroplasty

Eligibility

Ages Eligible for Study:	19 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

No contralateral hip symptoms, no major comorbidity

Exclusion Criteria:

-

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00175461

Locations

Canada, British Columbia
Vancouver General Hospital
Vancouver, British Columbia, Canada, V5Z 1L8

Sponsors and Collaborators

University of British Columbia

Investigators

Principal Investigator:

Nelson Greidanus, MD

University of British Columbia

More Information

No publications provided

Responsible Party:	University of British Columbia ( Dr. Nelson Greidanus )
Study ID Numbers:	C04-0070
Study First Received:	September 11, 2005
Last Updated:	April 17, 2009
ClinicalTrials.gov Identifier:	NCT00175461 History of Changes
Health Authority:	Canada: Health Canada

Study placed in the following topic categories:

Musculoskeletal Diseases
Osteoarthritis
Joint Diseases
Arthritis
Rheumatic Diseases

Additional relevant MeSH terms:

Musculoskeletal Diseases
Osteoarthritis
Joint Diseases
Arthritis
Rheumatic Diseases

ClinicalTrials.gov processed this record on September 02, 2009